Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dental implants under study to help people with tooth loss

NCT ID NCT07633665

Disease control Sponsor: Değirmenci Otomotiv ve Metal Endüstri A.Ş. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing two types of dental implants, BIODENTOSS and DWC, in 80 people who have lost teeth. The implants are placed in the jawbone, and after healing, artificial teeth are attached. Researchers will check how well the implants stay in place, how much bone is kept, and any side effects over 24 months. The goal is to see if these implants are a safe and effective way to replace missing teeth.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
BIODENTOSS and DWC dental implants and superstructures
What this could lead to
If successful, this could confirm that these dental implants are a safe and effective option for replacing missing teeth, helping people chew and smile with confidence.
What could go wrong
This is a post-market study, so the implants are already approved. Risks include implant failure, infection, or bone loss, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Jul 2028

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years of age or older, * Male or female, * Subjects with missing tooth who require dental implant treatment, * At least 2 months elapsed since tooth extraction, * General health status suitable for implantation, * Not legally restricted (e.g., soldier, convict), * Provision of signed Informed Consent Form (ICF) Exclusion Criteria: * Suspected or confirmed pregnancy or breastfeeding, * Disorders preventing adequate daily oral hygiene, * Hypersensitivity/allergy to titanium or implant components, * Inappropriate interarch relationship or parafunction (e.g., bruxism), * Bone/soft tissue deficiency requiring augmentation, * Active periodontal infection or untreated oral pathologies, * Unstable systemic diseases affecting wound healing (e.g., diabetes), * Use of immunosuppressive drug therapy due to systemic disorders, organ transplantation, or any other medical conditions, * Hematological disorders or current use of anticoagulants (such as Warfarin, dabigatran or related therapies), * Presence of osteoporosis and/or any disease condition affecting bone metabolism, * Presence of an active systemic infection, or any health condition or ongoing treatment (e.g., radiotherapy, bisphosphonate therapy) that contraindicates elective surgery, * Recent myocardial infarction or cerebrovascular event, * Individuals who consume high doses of alcohol, cigarettes, or tobacco products and are unable to control their usage, * Participation in another interventional clinical study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Edentulism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Tooth Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Edentulism Tooth loss

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Selcuk University, Faculty of Dentistry, Dept. of Oral and Maxillofacial Surgery.

    RECRUITING

    Konya, 42130, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.